OptiBiotix Health PLC Investor Meeting

​OptiBiotix reported a breakthrough in the manufacture of its SweetBiotix products on 24 November 2025 leading to higher yields of purer, more concentrated, better tasting product with lower ingredient and production costs.

​The Company is now in a position to demonstrate this product to shareholders at our in person event in London on the 24th June from 7pm- 8 30pm

​The meeting will give an overview of the commercial progress of the Company's first generation products, second generation products and their route to market, and sampling of SweetBiotix.